Litcius/Paper detail

Repurposing approved protein kinase inhibitors as potent anti-leishmanials targeting Leishmania MAP kinases

Anindita Bhattacharjee, Arka Bagchi, Solanki Sarkar, Sriparna Bawali, Arijit Bhattacharya, Arunima Biswas

2024Life Sciences11 citationsDOI

Topics & Concepts

RepurposingKinaseLeishmaniaDrug repositioningMitogen-activated protein kinasePharmacologyBiologyBiochemistryDrugComputer scienceParasite hostingEcologyWorld Wide WebResearch on Leishmaniasis StudiesChronic Myeloid Leukemia TreatmentsMelanoma and MAPK Pathways
Repurposing approved protein kinase inhibitors as potent anti-leishmanials targeting Leishmania MAP kinases | Litcius